| Nelarabine studied in …STUDIED_INderived32 of 32show fewer |
|---|
| → studied in | NCT06390319Phase 2 · recruiting Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia,T-Cell Non-Hodgkin Lymphoma,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072585Phase 2/Phase 3 · not yet recruiting Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) · 32 trials list this drug (6 active) | — | — | T Lymphoblastic Leukemia/Lymphoma,T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020030Phase 3 · active not recruiting Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents · 32 trials list this drug (6 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00501826Phase 2 · recruiting Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408005Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 32 trials list this drug (6 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03808610Phase 1/Phase 2 · terminated Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia · 32 trials list this drug (6 active) | — | — | B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07294677Phase 1/Phase 2 · recruiting CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL · 32 trials list this drug (6 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02881086Phase 3 · completed Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment · 32 trials list this drug (6 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01085617completed Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia · 32 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06434467Phase 3 · unknown The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma · 32 trials list this drug (6 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210750Phase 2 · withdrawn Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia,T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02763384Phase 2 · terminated BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia,Adult T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03328104Phase 1 · completed Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma · 32 trials list this drug (6 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684619Phase 2 · completed 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981799Phase 1/Phase 2 · terminated Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01094860Phase 1 · completed Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies · 32 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02619630Phase 2 · unknown Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old) · 32 trials list this drug (6 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02518750Phase 2 · terminated Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma · 32 trials list this drug (6 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00406757Phase 1 · completed Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma · 32 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01376115completed Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg · 32 trials list this drug (6 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004239Phase 1 · terminated 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment · 32 trials list this drug (6 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006020Phase 2 · completed S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia · 32 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866671completed Observational Study of Nelarabine in Children and Young Adults · 32 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003635Phase 2 · completed 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents · 32 trials list this drug (6 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002970Phase 2 · completed 506U78 in Treating Patients With Refractory Hematologic Cancer · 32 trials list this drug (6 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood Lymphoblastic Lymphoma,Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003837NA · completed 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · 32 trials list this drug (6 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003545Phase 2 · completed 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 32 trials list this drug (6 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005950Phase 2 · terminated 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma · 32 trials list this drug (6 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Small Lymphocytic Lymphoma,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005982Phase 2 · terminated 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma · 32 trials list this drug (6 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005080Phase 2 · completed 506U78 in Treating Patients With Lymphoma · 32 trials list this drug (6 active) | — | — | Anaplastic Large Cell Lymphoma,Adult T-Cell Leukemia/Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016302NA · completed Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 32 trials list this drug (6 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |